$58.31
-0.0800 (-0.137%)
At Close: Jun 03, 2026
Sherlock Biosciences Receives FDA Emergency Use Authorization for CRISPR SARS-CoV-2 Rapid Diagnostic
12:00am, Thursday, 07'th May 2020
Sherlock Biosciences Receives FDA Emergency Use Authorization for CRISPR SARS-CoV-2 Rapid Diagnostic
Exponent, Inc. (EXPO) today announced that due to current shelter in place orders in the San Francisco Bay Area and public health concerns regarding the COVID-19 pandemic and the welfare of our stockh
Redwood Investments, LLC Buys Horizon Therapeutics PLC, NovoCure, Tetra Tech Inc, Sells Funko ...
12:00am, Wednesday, 06'th May 2020Crown Advisors Management, Inc. Buys Onto Innovation Inc, ICU Medical Inc, Quidel Corp, Sells ...
12:00am, Tuesday, 05'th May 2020Exponent, Inc. Just Recorded A 15% EPS Beat: Here's What Analysts Are Forecasting Next
02:01pm, Sunday, 03'rd May 2020
Last week, you might have seen that Exponent, Inc. (NASDAQ:EXPO) released its quarterly result to the market. The...
Analysts Offer Insights on Services Companies: Exponent (EXPO) and Altice Usa (ATUS)
05:42pm, Friday, 01'st May 2020
Analysts have been eager to weigh in on the Services sector with new ratings on Exponent (EXPO) and Altice Usa (ATUS). Exponent (EXPO) Sidoti analyst Marc
Sidoti & Co. Maintains Neutral on Exponent, Raises Price Target to $80
01:46pm, Friday, 01'st May 2020Edited Transcript of EXPO earnings conference call or presentation 30-Apr-20 8:30pm GMT
10:45am, Friday, 01'st May 2020
Q1 2020 Exponent Inc Earnings Call
Exponent (NASDAQ:EXPO) Downgraded by BidaskClub to "Buy"
07:48am, Friday, 01'st May 2020
Exponent (NASDAQ:EXPO) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a report issued on Friday, BidAskClub reports. A number of other equ
Exponent Inc. (EXPO) Q1 2020 Earnings Call Transcript
03:31am, Friday, 01'st May 2020
EXPO earnings call for the period ending April 3, 2020.
Exponent's (EXPO) CEO Catherine Corrigan on Q1 2020 Results - Earnings Call Transcript
02:11am, Friday, 01'st May 2020
Exponent, Inc. (NASDAQ:EXPO) Q1 2020 Earnings Conference Call April 30, 2020 4:30 PM ET Company Participants Whitney Kukulka – Investor Relations Catherine Corr
Exponent (EXPO) Q1 Earnings and Revenues Beat Estimates
12:25am, Friday, 01'st May 2020
Exponent (EXPO) delivered earnings and revenue surprises of 11.36% and 0.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Exponent (EXPO) Q1 Earnings and Revenues Beat Estimates
12:25am, Friday, 01'st May 2020
Exponent (EXPO) delivered earnings and revenue surprises of 11.36% and 0.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Exponent: 1Q Earnings Snapshot
11:14pm, Thursday, 30'th Apr 2020
MENLO PARK, Calif. (AP) _ Exponent Inc. (EXPO) on Thursday reported first-quarter net income of $26.3 million. The Menlo Park, California-based company said it had profit of 49 cents per share. The en
Exponent: 1Q Earnings Snapshot
11:13pm, Thursday, 30'th Apr 2020
MENLO PARK, Calif. (AP) _ Exponent Inc. (EXPO) on Thursday reported first-quarter net income of $26.3 million.
The Menlo Park, California-based company said it had profit of 49 cents per share.
The en
Sign In
Buy EXPO